What is the appropriate treatment and management for a subconjunctival hemorrhage?

Subconjunctival Hemorrhage Treatment

Subconjunctival hemorrhage requires no specific treatment in the vast majority of cases, as it is a benign, self-limited condition that resolves spontaneously within 1-2 weeks through natural reabsorption.

Management Approach

Observation and Reassurance

• No active intervention is needed for uncomplicated subconjunctival hemorrhage 1, 2
• The blood reabsorbs spontaneously without treatment 1
• Reassure patients about the benign nature and expected resolution 1

Identify and Address Underlying Causes

Perform a comprehensive workup to rule out serious etiologies 1:

• Trauma history: Most common cause across all ages, accounting for the majority of cases 3
• Medication review: Anticoagulants (warfarin, aspirin) can cause recurrent or severe hemorrhages 4, 5
• Systemic disease screening: Hypertension, diabetes, arteriosclerosis in elderly patients 2
• Bleeding disorders: Consider if hemorrhages are recurrent, bilateral, or severe 4, 2
• Contact lens usage: Common risk factor in younger patients 2

When Further Evaluation Is Warranted

Pursue additional workup in these specific scenarios 2:

• Recurrent subconjunctival hemorrhages
• Persistent hemorrhage beyond expected timeframe
• Bilateral presentation
• Severe or extensive hemorrhage
• Associated systemic symptoms

Evaluate for 2:

• Systemic hypertension
• Coagulation disorders (check PT/PTT if on anticoagulation) 4
• Systemic or ocular malignancies
• Drug side effects

Prevention Strategies

For patients undergoing procedures (e.g., intravitreal injections):

• Topical oxymetazoline 30 minutes before injection reduces incidence from 72% to 51% 6
• This is a cost-effective, harmless intervention that improves patient satisfaction 6

Common Pitfalls to Avoid

• Do not attribute subconjunctival hemorrhage to cough, vomiting, or constipation in children under 3 years 7. These symptoms are rarely associated with SCH (0.4-0.5 per 1000), and alternative diagnoses including abuse must be carefully considered 7, 3
• Do not overlook trauma as the primary cause: In children, 83% of non-surgical SCH cases are trauma-related 3
• Do not dismiss recurrent cases: These mandate investigation for blood dyscrasias, clotting disorders, or systemic vascular disease 4, 2

Follow-Up

• Routine follow-up is unnecessary for simple, isolated cases 1
• Schedule return visit only if hemorrhage persists beyond 2-3 weeks or recurs 2